🇺🇸 FDA

Drug profile · INN

dronedarone

MULTAQ

FDA: approved EMA: approved C01BD07
US status
approved
Patents linked
0
News articles
0

Quick answer

dronedarone (MULTAQ) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN dronedarone
Brand MULTAQ
Route ORAL
Formulation TABLET
ATC code C01BD07
Originator Amneal Pharma Europe Ltd

Frequently asked questions

What is dronedarone?

dronedarone (MULTAQ) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for dronedarone?

MULTAQ is a marketed brand name for dronedarone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dronedarone?

dronedarone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.